Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Repare Therapeutics Inc (NQ: RPTX ) 3.540 +0.010 (+0.28%) Streaming Delayed Price Updated: 4:00 PM EDT, Jun 24, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Headline News about Repare Therapeutics Inc < Previous 1 2 3 Next > Why Upstart Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session May 08, 2024 Via Benzinga Why RingCentral Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket May 08, 2024 Via Benzinga Recap: Repare Therapeutics Q4 Earnings February 28, 2024 Via Benzinga Recap: Repare Therapeutics Q3 Earnings November 09, 2023 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session May 08, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday May 08, 2024 We're diving into the biggest pre-market stock movers for Wednesday will a look at all of the latest news happening this morning. Via InvestorPlace RPTX Stock Earnings: Repare Therapeutics Beats EPS, Beats Revenue for Q1 2024 May 07, 2024 RPTX stock results show that Repare Therapeutics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. Via InvestorPlace Roche's Lymphoma Drug With Chemo Extends Survival In Pretreated Patients April 15, 2024 Roche study results show prolonged survival in R/R diffuse large B-cell lymphoma patients treated with Columvi (glofitamab) + GemOx vs. Rituxan + GemOx. Via Benzinga Wall Street Thinks This Cathie Wood Stock Could Jump by 187% August 16, 2023 This small-cap biotech stock holds enormous growth potential. Via The Motley Fool Analyst Expectations for Repare Therapeutics's Future June 09, 2023 Via Benzinga Recap: Repare Therapeutics Q1 Earnings May 09, 2023 Via Benzinga Analyst Expectations for Repare Therapeutics's Future April 27, 2023 Via Benzinga Roche Terminates Cancer Drug Pact With Repare Therapeutics, Its Second Walkout Within A Month February 13, 2024 Repare Therapeutics regains global rights to camonsertib (RP-3500) after terminating collaboration with Roche. $40M milestone achieved. Via Benzinga These Biotech Stocks Could Double Your Money, According To Analysts November 09, 2023 Via Benzinga $2.8M Bet On Repare Therapeutics? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying November 06, 2023 The Dow Jones closed higher by over 200 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders... Via Benzinga Topics Stocks Exposures US Equities 12 Health Care Stocks Moving In Monday's Pre-Market Session November 06, 2023 Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session August 10, 2023 Via Benzinga 4 Analysts Have This to Say About Repare Therapeutics April 27, 2023 Via Benzinga Repare Therapeutics's Return On Capital Employed Insights December 16, 2022 Via Benzinga Why ParaZero Technologies Shares Are Trading Higher By Over 100%? Here Are Other Stocks Moving In Monday's Mid-Day Session October 09, 2023 Gainers ParaZero Technologies Ltd. (NASDAQ: PRZO) shares jumped 106% to $2.3901 after the company announced an Australian regulator approved first commercial drone flights in populated areas and near... Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For June 9, 2023 June 09, 2023 Via Benzinga Repare Therapeutics Releases Early Anticancer Activity From Its Monotherapy, Combination Trials June 08, 2023 Repare Therapeutics Inc (NASDAQ: RPTX) reported initial proof of concept monotherapy data from its Phase 1 MYTHIC trial evaluating lunresertib (RP-6306) in molecularly selected Via Benzinga Cathie Wood Has Been Building Stakes In Two Little-Known Stocks February 10, 2023 Cathie Wood – the billionaire investor who recently called her flagship fund “the new Nasdaq” has been loading up on shares of the following two small-cap stocks in recent days. Via Talk Markets Benzinga's Top Ratings Upgrades, Downgrades For February 3, 2023 February 03, 2023 Via Benzinga Credit Suisse, Autodesk And Other Big Losers From Wednesday November 25, 2022 U.S. stocks closed higher on Wednesday, with the Nasdaq Composite gaining more than 100 points. Here is the list of some big stocks recording losses in the previous session. Via Benzinga Quest Diagnostics To Plunge 16%? Here Are 5 Other Price Target Changes For Thursday November 17, 2022 Via Benzinga Biotech ETF Tops in June: 5 Stocks That Outperform June 30, 2022 Although most of the stocks in BBC’s portfolio have delivered strong returns this year so far, a few have gained more than 45%. Via Talk Markets The Daily Biotech Pulse: Roche's Alzheimer's Drug Fails, Advisors Back Pfizer, Moderna Shots For Youngest Kids, Valneva Settles COVID-19 Pact With UK June 16, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga United Airlines And 3 Other Stocks Insiders Are Buying June 07, 2022 Although US stocks closed slightly higher on Monday, there were a few notable insider trades. Via Benzinga 74 Biggest Movers From Yesterday June 03, 2022 Gainers Via Benzinga < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.